Company Pieris Pharmaceuticals Inc OTC Bulletin Board
Equities
PIRS
US7207951036
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
Apr. 19 | Pieris Pharmaceuticals Shares Fall After 1-for-80 Reverse Stock Split Announcement | MT |
Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biotechnological Applications
100.0
%
| 26 | 100.0 % | 43 | 100.0 % | +65.28% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States, Germany and Australia
100.0
%
| 26 | 100.0 % | 43 | 100.0 % | +65.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Yoder
CEO | Chief Executive Officer | 48 | 09-12-31 |
Thomas Bures
DFI | Director of Finance/CFO | 49 | 17-11-30 |
Kayti Aviano
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Hitto Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 53 | 19-08-29 |
Shane Olwill
PRN | Corporate Officer/Principal | 48 | 11-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 16-09-19 | |
James Geraghty
CHM | Chairman | 70 | 17-05-21 |
Michael Richman
BRD | Director/Board Member | 63 | 14-12-16 |
Matthew Sherman
BRD | Director/Board Member | 68 | 18-10-24 |
Peter Kiener
BRD | Director/Board Member | 72 | 18-09-09 |
Stephen Yoder
CEO | Chief Executive Officer | 48 | 09-12-31 |
Maya Said
BRD | Director/Board Member | 47 | 19-07-30 |
Ann Barbier
BRD | Director/Board Member | 59 | 18-04-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,506 | 0 | 0 | 92.57 % |
Stock B | 0 | 4,026 | 0 | 0 | |
Stock C | 1 | 1,236,688 | 1,144,742 ( 92.57 %) | 0 | |
Stock D | 0 | 85 | 0 | 0 |
Company contact information
Pieris Pharmaceuticals, Inc.
225 Franklin Street 9th floor
02109, Boston
+857 246 8998
http://www.pieris.comSector
1st Jan change | Capi. | |
---|---|---|
-1.65% | 103B | |
+6.75% | 101B | |
+6.52% | 23.07B | |
-12.60% | 22.23B | |
-5.61% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- PIRS Stock
- PIRS Stock
- Company Pieris Pharmaceuticals Inc